Point mutational inactivation of the retinoblastoma antioncogene.

Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc Natl Acad Sci U S A (1992) 4.27

Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proc Natl Acad Sci U S A (1990) 4.06

Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F. Mol Cell Biol (1992) 3.58

Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol Cell Biol (1993) 3.54

The retinoblastoma protein is phosphorylated on multiple sites by human cdc2. EMBO J (1991) 3.15

The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations. EMBO J (1990) 2.80

Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene. Mol Cell Biol (1992) 2.78

Detection of DNA sequence polymorphisms by enzymatic amplification and direct genomic sequencing. Am J Hum Genet (1989) 2.68

A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding. Proc Natl Acad Sci U S A (1990) 2.46

Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility. Mol Cell Biol (1997) 2.45

Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. Am J Hum Genet (1991) 2.45

Definition of the minimal simian virus 40 large T antigen- and adenovirus E1A-binding domain in the retinoblastoma gene product. Mol Cell Biol (1990) 2.27

Nonfunctional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association, and nuclear tethering. Proc Natl Acad Sci U S A (1991) 2.26

Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigen. EMBO J (1990) 2.26

The retinoblastoma gene product regulates Sp1-mediated transcription. Mol Cell Biol (1992) 2.21

Antibodies specific for the human retinoblastoma protein identify a family of related polypeptides. Mol Cell Biol (1991) 2.20

The E7 proteins of the nononcogenic human papillomavirus type 6b (HPV-6b) and of the oncogenic HPV-16 differ in retinoblastoma protein binding and other properties. J Virol (1990) 2.19

Loss of p53 protein in human papillomavirus type 16 E6-immortalized human mammary epithelial cells. J Virol (1991) 2.14

Biological function of the retinoblastoma protein requires distinct domains for hyperphosphorylation and transcription factor binding. Mol Cell Biol (1992) 2.13

Mechanisms of p53 loss in human sarcomas. Proc Natl Acad Sci U S A (1990) 2.03

Mutations in the RB1 gene and their effects on transcription. Mol Cell Biol (1989) 2.00

TATA-binding protein and the retinoblastoma gene product bind to overlapping epitopes on c-Myc and adenovirus E1A protein. Proc Natl Acad Sci U S A (1993) 2.00

The transcription factor E2F-1 is a downstream target of RB action. Mol Cell Biol (1995) 1.97

Physical and functional interaction between WT1 and p53 proteins. Proc Natl Acad Sci U S A (1993) 1.96

Negative regulation of DNA replication by the retinoblastoma protein is mediated by its association with MCM7. Mol Cell Biol (1998) 1.92

C-terminal truncation of the retinoblastoma gene product leads to functional inactivation. Proc Natl Acad Sci U S A (1990) 1.91

Role of pRb-related proteins in simian virus 40 large-T-antigen-mediated transformation. Mol Cell Biol (1995) 1.87

Multiple members of the E2F transcription factor family are the products of oncogenes. Proc Natl Acad Sci U S A (1995) 1.86

Sp-1 binds promoter elements regulated by the RB protein and Sp-1-mediated transcription is stimulated by RB coexpression. Proc Natl Acad Sci U S A (1993) 1.84

A maize cDNA encoding a member of the retinoblastoma protein family: involvement in endoreduplication. Proc Natl Acad Sci U S A (1996) 1.81

Subunit composition determines E2F DNA-binding site specificity. Mol Cell Biol (1997) 1.75

Distinct sub-populations of the retinoblastoma protein show a distinct pattern of phosphorylation. EMBO J (1994) 1.67

Regulation of transforming growth factor beta 1 gene expression by the product of the retinoblastoma-susceptibility gene. Proc Natl Acad Sci U S A (1991) 1.63

Functional interactions between the retinoblastoma (Rb) protein and Sp-family members: superactivation by Rb requires amino acids necessary for growth suppression. Proc Natl Acad Sci U S A (1995) 1.61

Expression and state of phosphorylation of the retinoblastoma susceptibility gene product in cycling and noncycling human hematopoietic cells. Proc Natl Acad Sci U S A (1990) 1.57

Oncogenic point mutations in exon 20 of the RB1 gene in families showing incomplete penetrance and mild expression of the retinoblastoma phenotype. Proc Natl Acad Sci U S A (1992) 1.54

Mutational analysis of the DRA promoter: cis-acting sequences and trans-acting factors. Mol Cell Biol (1990) 1.52

The retinoblastoma protein physically associates with the human cdc2 kinase. Mol Cell Biol (1992) 1.40

Identification of intronic point mutations as an alternative mechanism for p53 inactivation in lung cancer. J Clin Invest (1990) 1.38

DNA-binding properties of the E1A-associated 300-kilodalton protein. Mol Cell Biol (1992) 1.31

The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells. Proc Natl Acad Sci U S A (1991) 1.29

Sample type bias in the analysis of cancer genomes. Cancer Res (2009) 1.22

BK virus large T antigen: interactions with the retinoblastoma family of tumor suppressor proteins and effects on cellular growth control. J Virol (1996) 1.22

Adenovirus E1A is associated with a serine/threonine protein kinase. J Virol (1991) 1.19

Transcriptional repression and growth suppression by the p107 pocket protein. Mol Cell Biol (1996) 1.18

Hyperphosphorylation of the retinoblastoma gene product is determined by domains outside the simian virus 40 large-T-antigen-binding regions. Mol Cell Biol (1990) 1.16

p53 and retinoblastoma pathways in bladder cancer. World J Urol (2007) 1.16

A cellular repressor of E1A-stimulated genes that inhibits activation by E2F. Mol Cell Biol (1998) 1.14

Purification and characterization of human papillomavirus type 16 E7 protein with preferential binding capacity to the underphosphorylated form of retinoblastoma gene product. J Virol (1991) 1.14

p53, Rb and bcl-2 expression during the cell cycle: a study in phytohaemagglutinin stimulated lymphocytes and microwave irradiated lymphoid tissue sections. J Clin Pathol (1995) 1.13

Expression and interactions of human adenovirus oncoproteins. Biochem J (1991) 1.10

Role of the retinoblastoma gene in the initiation and progression of human cancer. J Clin Invest (1990) 1.10

Novel mechanisms of E2F induction by BK virus large-T antigen: requirement of both the pRb-binding and the J domains. Mol Cell Biol (1998) 1.09

Human bladder carcinoma cell lines as indicators of oncogenic change relevant to urothelial neoplastic progression. Br J Cancer (1995) 1.09

The genetics of retinoblastoma. Br J Cancer (1991) 1.07

Deletion of RB exons 24 and 25 causes low-penetrance retinoblastoma. Am J Hum Genet (1997) 1.07

Exon skipping during splicing of albumin mRNA precursors in Nagase analbuminemic rats. Proc Natl Acad Sci U S A (1990) 1.05

Human papillomavirus type 16 E7 protein inhibits DNA binding by the retinoblastoma gene product. Mol Cell Biol (1992) 1.03

Molecular analysis of selected cell cycle regulatory proteins during aerobic and hypoxic maintenance of human ovarian carcinoma cells. Br J Cancer (1999) 1.01

Correlation between retinoblastoma gene expression and differentiation in human testicular tumors. Proc Natl Acad Sci U S A (1991) 1.00

Somatic mosaicism in a patient with bilateral retinoblastoma. Am J Hum Genet (1990) 0.95

The retinoblastoma tumor suppressor protein targets distinct general transcription factors to regulate RNA polymerase III gene expression. Mol Cell Biol (2000) 0.95

p107 in the public eye: an Rb understudy and more. Cell Div (2010) 0.94

Simian virus 40 can overcome the antiproliferative effect of wild-type p53 in the absence of stable large T antigen-p53 binding. J Virol (1991) 0.94

Retinoblastoma (RB1) gene product expression in breast carcinoma. Correlation with Ki-67 growth fraction and biopathological profile. J Clin Pathol (1998) 0.92

Coexpression of cdk2/cdc2 and retinoblastoma gene products in colorectal cancer. Br J Cancer (1995) 0.90

Molecular mechanisms of transformation of C3H/10T1/2 C1 8 mouse embryo cells and diploid human fibroblasts by carcinogenic metal compounds. Environ Health Perspect (1994) 0.90

Chronic lymphocytic leukemia cells with allelic deletions at 13q14 commonly have one intact RB1 gene: evidence for a role of an adjacent locus. Proc Natl Acad Sci U S A (1993) 0.89

Retinoblastoma gene mutations in primary human bladder cancer. Br J Cancer (1995) 0.87

Retinoblastoma gene structure and product expression in human gastric carcinomas. Br J Cancer (1994) 0.85

Nontumorigenic squamous cell carcinoma line converted to tumorigenicity with methyl methanesulfonate without activation of HRAS or MYC. Proc Natl Acad Sci U S A (1990) 0.84

Rb inhibits the intrinsic kinase activity of TATA-binding protein-associated factor TAFII250. Mol Cell Biol (1999) 0.82

Application of PCR amplification of DNA from paraffin embedded tissue sections to linkage analysis in familial retinoblastoma. J Med Genet (1991) 0.82

The orf13 T-DNA gene of Agrobacterium rhizogenes confers meristematic competence to differentiated cells. Plant Physiol (2004) 0.82

Trilateral retinoblastoma in transgenic mice. Trans Am Ophthalmol Soc (1989) 0.81

Invasiveness and metastasis of retinoblastoma in an orthotopic zebrafish tumor model. Sci Rep (2015) 0.79

Detection of Heterozygous Mutation in the Retinoblastoma Gene in a Human Pituitary Adenoma Using PCR-SSCP Analysis and Direct Sequencing. Endocr Pathol (1995) 0.78

Suppression of the chemically transformed phenotype of BHK cells by a human cDNA. Mol Cell Biol (1991) 0.77

Transcriptional regulation of Sox2 by the retinoblastoma family of pocket proteins. Oncotarget (2015) 0.76

Functional in vitro assays for the isolation of cell transformation effector and suppressor genes. Environ Health Perspect (1991) 0.76

Anomalous retinoblastoma protein expression in Sternberg-Reed cells in Hodgkin's disease: a comparative study with p53 and Ki67 expression. Br J Cancer (1996) 0.75

Equal parental origin of chromosome 22 losses in human sporadic meningioma: no evidence for genomic imprinting. Am J Hum Genet (1990) 0.75

Tumor-suppressor genes: cardinal factors in inherited predisposition to human cancers. Environ Health Perspect (1992) 0.75

The hallmarks of cancer. Cell (2000) 113.05

The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature (1997) 33.47

Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature (1983) 19.76

Tumor spectrum analysis in p53-mutant mice. Curr Biol (1994) 16.60

The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science (1989) 16.54

Creation of human tumour cells with defined genetic elements. Nature (1999) 16.47

hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell (2001) 15.97

Monoclonal antibodies specific for simian virus 40 tumor antigens. J Virol (1981) 15.59

A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature (1986) 13.96

Mechanism of activation of a human oncogene. Nature (1982) 12.09

Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature (1983) 11.57

Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev (2001) 11.25

Effects of an Rb mutation in the mouse. Nature (1992) 11.06

Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature (1988) 10.98

hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell (1997) 8.74

Distinct roles for cyclin-dependent kinases in cell cycle control. Science (1993) 8.13

Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu Rev Immunol (1997) 7.76

Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J (1989) 7.69

Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell (1992) 7.61

Cellular targets for transformation by the adenovirus E1A proteins. Cell (1989) 7.53

Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature (1993) 7.20

Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation. Nature (1985) 7.07

Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell (1986) 7.06

Multiple protein-binding sites in the 5'-flanking region regulate c-fos expression. Mol Cell Biol (1986) 7.06

New functional activities for the p21 family of CDK inhibitors. Genes Dev (1997) 6.97

Isolation of a transforming sequence from a human bladder carcinoma cell line. Cell (1982) 6.93

The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell (1989) 6.68

Cellular oncogenes and multistep carcinogenesis. Science (1983) 6.52

A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell (1992) 6.32

The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen. Nature (1985) 6.23

A point mutation of the rhodopsin gene in one form of retinitis pigmentosa. Nature (1990) 6.19

Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene. Nature (1982) 6.09

Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell (1995) 6.08

Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J Immunol (1999) 5.86

The integrated genome of murine leukemia virus. Cell (1978) 5.84

The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature (1986) 5.77

Monoclonal antibodies specific for adenovirus early region 1A proteins: extensive heterogeneity in early region 1A products. J Virol (1985) 5.69

Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev (1993) 5.54

The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing. N Engl J Med (1992) 5.51

Passage of phenotypes of chemically transformed cells via transfection of DNA and chromatin. Proc Natl Acad Sci U S A (1979) 5.32

Physical interaction of the retinoblastoma protein with human D cyclins. Cell (1993) 5.31

Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol (2000) 5.28

Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol Cell Biol (1994) 5.18

Acrylamide gel electrophoresis of HeLa cell nucleolar RNA. Proc Natl Acad Sci U S A (1967) 5.06

Small molecular weight monodisperse nuclear RNA. J Mol Biol (1968) 4.96

A family of human cdc2-related protein kinases. EMBO J (1992) 4.96

Inhibition of telomerase limits the growth of human cancer cells. Nat Med (1999) 4.96

Association of a murine 53,000-dalton phosphoprotein with simian virus 40 large-T antigen in transformed cells. J Virol (1980) 4.88

Digenic retinitis pigmentosa due to mutations at the unlinked peripherin/RDS and ROM1 loci. Science (1994) 4.86

Tumor induction and tissue atrophy in mice lacking E2F-1. Cell (1996) 4.80

Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature (1981) 4.72

Reverse two-hybrid and one-hybrid systems to detect dissociation of protein-protein and DNA-protein interactions. Proc Natl Acad Sci U S A (1996) 4.70

Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase. Cell (1992) 4.68

Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol (1998) 4.54

Isolation of the human cdk2 gene that encodes the cyclin A- and adenovirus E1A-associated p33 kinase. Nature (1991) 4.36

Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F. Nature (1992) 4.21

DNA sequences homologous to vertebrate oncogenes are conserved in Drosophila melanogaster. Proc Natl Acad Sci U S A (1981) 4.17

Suppression of intestinal neoplasia by DNA hypomethylation. Cell (1995) 4.16

Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation. Genes Dev (1993) 4.14

Association of adenovirus early-region 1A proteins with cellular polypeptides. Mol Cell Biol (1986) 4.14

Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci U S A (1997) 4.11

Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. Proc Natl Acad Sci U S A (1998) 4.11

Isolation and characterization of simian virus 40 ribonucleic acid. J Virol (1972) 4.09

Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proc Natl Acad Sci U S A (1990) 4.06

Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature (1996) 4.05

Restriction endonuclease cleavage of linear and closed circular murine leukemia viral DNAs: discovery of a smaller circular form. Cell (1979) 4.04

Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat Genet (1994) 3.97

Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes Dev (1992) 3.96

p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature (1994) 3.95

The retinoblastoma protein binds to a family of E2F transcription factors. Mol Cell Biol (1993) 3.75

A defined subgenomic fragment of in vitro synthesized Moloney sarcoma virus DNA can induce cell transformation upon transfection. Cell (1979) 3.74

Deletions of a DNA sequence in retinoblastomas and mesenchymal tumors: organization of the sequence and its encoded protein. Proc Natl Acad Sci U S A (1987) 3.72

Identification of DNA fragments carrying ecotropic proviruses of AKR mice. Proc Natl Acad Sci U S A (1979) 3.64

The action of oncogenes in the cytoplasm and nucleus. Science (1985) 3.62

Shared role of the pRB-related p130 and p107 proteins in limb development. Genes Dev (1996) 3.61

Phenotype of mice lacking functional Deleted in colorectal cancer (Dcc) gene. Nature (1997) 3.57

Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea. Aliment Pharmacol Ther (2011) 3.56

Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol Cell Biol (1993) 3.54

A null mutation in the rhodopsin gene causes rod photoreceptor dysfunction and autosomal recessive retinitis pigmentosa. Nat Genet (1992) 3.51

Recessive mutations in the gene encoding the beta-subunit of rod phosphodiesterase in patients with retinitis pigmentosa. Nat Genet (1993) 3.49

Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp Cell Res (2001) 3.48

Differential regulation of E2F transactivation by cyclin/cdk2 complexes. Genes Dev (1994) 3.47

Cell cycle-specific association of E2F with the p130 E1A-binding protein. Genes Dev (1993) 3.41

Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature (1995) 3.41

Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes Dev (2000) 3.30

Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A. Proc Natl Acad Sci U S A (1998) 3.27

Characterization of a human colon/lung carcinoma oncogene. Nature (1983) 3.26

Transgenic mice with a rhodopsin mutation (Pro23His): a mouse model of autosomal dominant retinitis pigmentosa. Neuron (1992) 3.25

A paracrine role for the epithelial progesterone receptor in mammary gland development. Proc Natl Acad Sci U S A (1998) 3.23

Mutations in the RPE65 gene in patients with autosomal recessive retinitis pigmentosa or leber congenital amaurosis. Proc Natl Acad Sci U S A (1998) 3.22

An invariant T cell receptor alpha chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted alpha/beta T cell subpopulation in mammals. J Exp Med (1999) 3.20